GET THE APP

Antibacterials Regulating the Mucosal Epithelium
..

Oral Health Case Reports

ISSN: 2471-8726

Open Access

Editorial - (2022) Volume 8, Issue 3

Antibacterials Regulating the Mucosal Epithelium

Olivia Smith*
*Correspondence: Olivia Smith, Department of Oral Medicine and Periodontology, Faculty of Dental Sciences, University of Prince Edward Island, Charlottetown, Canada, Email:
Department of Oral Medicine and Periodontology, Faculty of Dental Sciences, University of Prince Edward Island, Charlottetown, Canada

Received: 17-Apr-2022, Manuscript No. OHCR-22-73201; Editor assigned: 20-Apr-2022, Pre QC No. P-73201; Reviewed: 25-Apr-2022, QC No. Q-73201; Revised: 04-May-2022, Manuscript No. R-73201; Published: 09-May-2022 , DOI: 10.37421/2471-8726.2022.8.51
Citation: Smith, Olivia. “Antibacterials Regulating the Mucosal Epithelium.” Oral Heath Case Rep 8 (2022): 51.
Copyright: © 2022 Smith O. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Editorial

Bacteria are the most prevalent and abundant germs, and the mouth offers an environment that is favourable for their colonisation and proliferation. Desquamation makes sure that the microbial burden is reduced on mucosal surfaces where the highest concentrations of bacteria are present as biofilms on the tooth surface. These bacteria are naturally present on all surfaces of the mouth that are accessible, and they are necessary for the healthy growth of the physiology of the oral cavity. By preventing foreign, possibly pathogenic microorganisms from colonising the mouth and by controlling the inflammatory host response to oral commensal bacteria, the local microflora supports the health of the host. The risk of illness can rise when the natural oral microflora is disrupted, leading to the overgrowth of previously small microflora components or the colonisation of environmental organisms.

The mouth is often home to a wide variety of advantageous microorganisms that coexist peacefully with the host and benefit both. In order to preserve the good effects of the native oral microbiota, oral healthcare solutions should aim to regulate the levels of plaque rather than aiming to remove it. An organised series of actions leads to the formation of dental plaque. After washing, the acquired pellicle instantly adheres to the tooth surface, where early colonising bacteria attach. These early colonisers expand, alter the environment, and provide favourable circumstances for later, more virulent bacteria to colonize many of which are compelled to be anaerobic. The biofilm matrix, which serves as a framework for the biofilm and is biologically active and able to hold molecules inside plaque, is created by attached organisms using exopolymers such glucans. A thick biofilm eventually forms, consisting of a varied population of interacting microorganisms, and its makeup stabilises over time. When a species is developing planktonically, its characteristics are different from those of a biofilm.

Instead of being colonised by ambient organisms or planktonic cultures, biofilms have a phenotype that is more resilient to stress, antimicrobial agents, and host defences. This disturbance can raise the risk of illness. Generally speaking, the mouth is home to a diverse population of advantageous microorganisms that coexist peacefully with the host and benefit both. Therefore, oral healthcare solutions should focus on reducing plaque levels rather than trying to completely remove it in order to preserve the positive effects of the natural oral bacteria. An organised series of actions leads to the formation of dental plaque. After washing, the acquired pellicle instantly adheres to the tooth surface, where early colonising bacteria attach. These early colonisers expand, alter the environment, and provide favourable circumstances for later, more virulent bacteria to colonize—many of which are compelled to be anaerobic. The biofilm matrix, which serves as a framework for the biofilm and is biologically active and able to hold molecules inside plaque, is created by attached organisms using exopolymers such glucans.

A thick biofilm eventually forms, made up of a varied population of interacting microbes, and its makeup settles down over time. Biofilms have different characteristics from the same species developing planktonically. It is challenging to treat biofilms because of their phenotype, which is more resistant to antimicrobial treatments, stress, and host defences than planktonic cultures. In dental plaque, microbial equilibrium occasionally fails, leading to disease. In stark contrast to healthy sites, sick sites have a distinct microbiota. These alterations in the microflora originate from changes in the environmental circumstances, which modify the competitiveness of the bacteria and select for previously unimportant members of the microbial community. Regular consumption of fermentable carbohydrates increases the amount of time plaque spends at a low pH, favouring species like mutans streptococci, other acidogenic streptococci, lactobacilli, and bifidobacteria while blocking healthrelated bacteria that prefer a neutral pH. In contrast, severe plaque buildup at the gingival border in periodontal disease results in an inflammatory reaction [1-5].

Conflict of Interest

None.

References

  1. Adolphs, H.D., and H. P. Bastian. "Chemoimmune prophylaxis of superficial bladder cancer." J Uro  Balt 129(1983): 29-31.
  2. Google Scholar, Crossref, Indexed at

  3. Bono, A. V., C. Benvenuti, G. Damiano, and J. Lovisolo. "Results of transurethral resection and intravesical doxorubicin prophylaxis in patients with T1 G3 bladder cancer." Urology 44 (1994): 329-334.
  4. Google Scholar, Crossref, Indexed at

  5. Ozono, Seiichiro, Shiro Hinotsu, Shoichi Tabata, and Kenji Takashima, et al. "Treated natural history of superficial bladder cancer." Jpn J Clin Oncol 31(2001): 536-540.
  6. Google Scholar, Crossref, Indexed at

  7. Gofrit, O. N., A. Shapiro, D. Pode, and A. Sidi, et al. "Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer." Urology 63(2004): 466-471.
  8. Google Scholar, Crossref, Indexed at

  9. Freeman, John A., David Esrig, John P. Stein, and Donald G. Skinner. "Management of the patient with bladder cancer: urethral recurrence." Urol Clin  North Am 21(1994): 645-651.
  10. Google Scholar, Crossref, Indexed at

arrow_upward arrow_upward